News
New CloudBolt Research: 86% of Companies Actively Reducing their VMware Footprint

New CloudBolt Research: 86% of Companies Actively Reducing their VMware Footprint

February 17, 2026

ROCKVILLE, Md. — CloudBolt Software, a recognized leader in cloud cost optimization and hybrid cloud management, today released a new research report, “The Mass Exodus That Never Was: The Squeeze Is Just Beginning,” examining how enterprise IT leaders are responding two years after Broadcom’s acquisition of VMware.

The report, based on a January 2026 survey of 302 IT decision-makers at North American enterprises (1,000+ employees) – and a follow up to a 2024 study on the same topic – finds that while the predicted immediate stampede away from VMware did not materialize, organizations are actively unwinding dependence in a measured, workload-by-workload transition — shaped by pricing concerns, operational complexity, and mounting executive scrutiny.

“Two years ago, the market was dominated by knee-jerk speculation and worst-case projections,” said Mark Zembal, Chief Marketing Officer at CloudBolt. “This latest study separates noise and speculation from reality. The fear has cooled, but the pressure hasn’t — and most teams are now making practical moves to build leverage and optionality — even if for some that includes the realization that a portion of their estate never moves off VMware.”

Key findings

CloudBolt’s research highlights three numbers that capture the market’s shift from fear to sustained pressure to action:

  • 2024 Fear: 73% expected VMware costs to more than double — yet only 5% of respondents to this most recent study have seen 100%+ increases.
  • 2026 Reality: 88% are concerned about future price increases, and say it is shaping decisions now as the real squeeze begins.
  • The Action: 86% report they are actively reducing their VMware footprint.

To put an even finer point on overall sentiment, one survey respondent commented, “The process of unwinding a decade of process dependencies is taking 18-24 months. This sideways abstraction is far more complex than a standard cloud lift-and-shift, leading to a significant loss of confidence in our ability to exit quickly enough to avoid the next renewal cliff.”  

Additional findings underscore why the “slow unwind” is becoming the dominant operating model:

  • 56% say they have changed their VMware strategy two or more times since the acquisition, reflecting a market still recalibrating and experimenting in real time.
  • 54% say they are staying with VMware while actively reducing dependence, signaling phased, partial transitions rather than immediate “full migration” exits.
  • 72% of migrating workloads are heading to public cloud IaaS, with Hyper-V/Azure Stack (38%) and SaaS replacements (34%) also popular components of the mix.

“Enterprises aren’t just asking what they want to do — they’re confronting what they can execute safely,” said Rod Squires, CEO of CloudBolt. “The panic phase is over. Now it’s execution: reducing dependency, managing dual realities during transition, and building optionality before the next renewal decision tightens the window – and slams the budget.”

Why this matters now

Two years in, VMware strategy has become a priority business-level decision, not just a technical one. 41% of respondents report increased executive pressure since the acquisition, as organizations weigh cost volatility, vendor risk, and the operational burden of multi-platform environments. The result is a market shifting from panic to execution —often through phased, workload-by-workload transitions.

Report access

The full report, “The Mass Exodus That Never Was: The Squeeze Is Just Beginning,” is available at: https://www.cloudbolt.io/industry-research/cii-the-mass-exodus-that-never-was/

More from Newsroom

Extra Duty Solutions Appoints Michael Nark as New CEO to Drive Technological Growth

Extra Duty Solutions names Michael Nark as CEO to lead innovation and expansion in its extra duty management platform, enhancing technology-driven services in the public safety SaaS sector.

May 27, 2026

Hansa Biopharma Announces Positive Results from Idefirix® Post-Authorization Study in Kidney Transplantation

Hansa Biopharma reports a 90% one-year graft failure-free survival rate in its European post-authorization study of Idefirix®, supporting the drug's full marketing authorization submission and confirming its safety profile.

April 1, 2024
No items found.

PowerX Launches PowerX Energy Blade, a Rack-Mounted Battery Energy Storage System for Data Centers

PowerX unveils the PowerX Energy Blade, a cutting-edge rack-mounted battery energy storage system specifically designed to enhance energy efficiency and reliability in data centers, driving innovations in enterprise infrastructure.

May 14, 2026